Among the numerous immune interactions, or lack-thereof, that occur during cancer
progression, tumor-associated macrophages (TAMs)–cancer cell interactions have been …

As one of the most abundant immune cell populations in the tumor microenvironment (TME),
tumor‐associated macrophages (TAMs) play important roles in multiple solid malignancies …

Cancer immunotherapy has revolutionized the paradigm for the clinical management of
cancer. While FDA-approved cancer immunotherapies thus far mainly exploit the adaptive …

Macrophages, a type of myeloid immune cell, play essential roles in fighting against
pathogenic invasion and activating T cell-mediated adaptive immune responses. As a major …

Targeted delivery of nanomedicines to M2 tumor-associated macrophages (TAMs) has been
proposed to reduce tumor promotion and enhance the efficacy of anticancer therapy …

Immunotherapy has achieved prominent clinical efficacy in combating cancer and has
recently become a mainstream treatment strategy. However, achieving broad efficacy with a …

Without coordinated strategies to mitigate the immunosuppressive nature of the tumor
microenvironment, cancer immunotherapy generally offers limited clinical benefit for …

Biomimetic approaches utilize natural cell membrane‐derived nanovesicles to camouflage
nanoparticles to circumvent some limitations of nanoscale materials. This emergent cell …

As an important part of tumor microenvironment, tumor associated macrophages (TAMs)
play a vital role in the occurrence, development, invasion, and metastasis of many malignant …

Immunotherapy has shown encouraging results in various cancers, but the response rates
are relatively low due to the complex tumor immunosuppressive microenvironment (TIME) …